Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Progyny, Inc.

NASDAQ: PGNY · Industrial Applications and Services · 9 alerts · CIK 1551306

Share price
$37.15Close, Nov 16
Market cap
$2.74B
Shares outstanding
73.65MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Misc Health & Allied Services, NECSIC 8090

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Progyny, Inc. filings on SEC EDGAR ↗

4:24 PM ET Form 4
Insider Selling

Progyny Chief Product Officer Geoffrey Clapp Sells $28.2K of Stock

Geoffrey Clapp, Chief Product Officer, sold 774 shares of Progyny, Inc. at $36.41 a share, worth $28.2K in total on Nov 11, 2026. Shares held after the trade: 58,235 (-1.3%).

Value
$28.2K
Shares
774
Price
$36.41
Role
Chief Product Officer
Holding change
-1.3%
Trade date
Nov 11, 2026
5:32 PM ET Form 4
Insider Selling

Progyny CEO Peter Anevski Sells $8.48M of Stock

Peter Anevski, CEO, sold 236,630 shares of Progyny, Inc. at $35.61 to $36.29 a share (average $35.84) in 4 transactions, worth $8.48M in total on Nov 10, 2026. Shares held after the trade: 710,972 (-2.5%).

Value
$8.48M
Shares
236,630
Average price
$35.84
Role
CEO
Holding change
-2.5%
Trade date
Nov 10, 2026
5:30 PM ET Form 4
Insider Selling

Progyny Executive Chairman David J. Schlanger Sells $1.25M of Stock

David J. Schlanger, Executive Chairman, sold 35,392 shares of Progyny, Inc. at $35.36 a share, worth $1.25M in total on Nov 10, 2026. Shares held after the trade: 238,462 (-12.9%).

Value
$1.25M
Shares
35,392
Price
$35.36
Role
Executive Chairman
Holding change
-12.9%
Trade date
Nov 10, 2026
12:06 AM ET Form 4
Insider Selling

Progyny CEO Peter Anevski Sells $6.18M of Stock

Peter Anevski, CEO, sold 173,247 shares of Progyny, Inc. at $35.09 to $35.73 a share (average $35.68) in 4 transactions, worth $6.18M in total between Nov 5, 2026 and Nov 9, 2026. Shares held after the trade: 762,468 (-4.4%).

Value
$6.18M
Shares
173,247
Average price
$35.68
Role
CEO
Holding change
-4.4%
Trade date
Nov 5, 2026 to Nov 9, 2026
12:06 AM ET Form 4
Insider Selling

Progyny Executive Chairman David J. Schlanger Sells $5.88M of Stock

David J. Schlanger, Executive Chairman, sold 164,608 shares of Progyny, Inc. at $35.22 to $35.73 a share (average $35.72) in 2 transactions, worth $5.88M in total between Nov 5, 2026 and Nov 9, 2026. Shares held after the trade: 238,462 (-40.3%).

Value
$5.88M
Shares
164,608
Average price
$35.72
Role
Executive Chairman
Holding change
-40.3%
Trade date
Nov 5, 2026 to Nov 9, 2026
4:07 PM ET Form 4
Insider Selling

Progyny CFO Mark S. Livingston Sells $64.2K of Stock

Mark S. Livingston, CFO, sold 2,139 shares of Progyny, Inc. at $30.00 a share, worth $64.2K in total on Nov 4, 2026. Shares held after the trade: 70,314 (-3.0%).

Value
$64.2K
Shares
2,139
Price
$30.00
Role
CFO
Holding change
-3.0%
Trade date
Nov 4, 2026
8:57 AM ET 10-Q
Financial Results

Progyny Q3 2026 Results: Net Income $26.3M, Up 89.4% YoY

Progyny, Inc. reported its financial results for the third quarter of 2026, maintaining its status as a large accelerated filer with 73,647,334 shares of common stock outstanding as of October 31, 2026. The filing highlights risks including high client concentration in the technology industry and the potential impact of evolving laws and regulations on reproductive rights.

Key figure
Net income $26.3M · +89.4% YoY
4:13 PM ET 8-K
Financial Results

Progyny Financial Results

Progyny reported record third-quarter 2026 results with revenue increasing 9% year-over-year to $341.3 million and net income nearly doubling to $26.3 million. The company achieved its strongest selling season ever, adding 1.3 million new covered lives for 2027 while maintaining near 100% client retention.

“We're exceptionally pleased with the results of our most recent selling season, where our momentum extended even into its latest stages, yielding 1.3 million new covered lives, our most ever in a single season, and over 85 new clients.”

Pete Anevski, Chief Executive Officer of Progyny

“We achieved strong top- and bottom-line growth this quarter, reflecting that member engagement was consistent with our expectations, and we are pleased to be in a position to raise the midpoint of our full year guidance.”

Mark Livingston, Chief Financial Officer of Progyny

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.